International Registry on the Use of the CytoSorb Adsorber

CompletedOBSERVATIONAL
Enrollment

1,434

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 4, 2021

Study Completion Date

February 4, 2021

Conditions
SepsisNeed of Cardiac Surgery
Interventions
DEVICE

Use of CytoSorb adsorber

Use of CytoSorb adsorber either in patients with severe sepsis/septic shock or with cardiac surgery with CPB or in other patients.

Trial Locations (19)

Unknown

Krankenhaus Hietzing, Vienna

Vivantes Klinikum Neukölln, Berlin

Evangelisches Krankenhaus, Bielefeld

Carl-Thiem-Klinikum, Cottbus

Universitätsklinikum Düsseldorf, Düsseldorf

Klinikum Emden, Emden

Kliniken Erlabrunn gGmbH, Erlabrunn

Universitätsklinikum Freiburg, Freiburg im Breisgau

Universitätsmedizin Göttingen, Göttingen

Greifswald University Hospital, Greifswald

Krankenhaus St. Elisabeth & St. Barbara, Halle

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Krankenhaus Herzberg, Elbe-Elster-Klinikum GmbH, Herzberg

Kliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach

Klinikum rechts der Isar der TU München, München

Klinikum Oldenburg, Oldenburg

University Hospital Ulm, Ulm

Kliniken Nordoberpfalz AG, Klinikum Weiden, Weiden

University of Szeged, Szeged

All Listed Sponsors
collaborator

University Hospital Goettingen

OTHER

lead

Jena University Hospital

OTHER

NCT02312024 - International Registry on the Use of the CytoSorb Adsorber | Biotech Hunter | Biotech Hunter